These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11313931)

  • 1. Cdk10, a Cdc2-related kinase, associates with the Ets2 transcription factor and modulates its transactivation activity.
    Kasten M; Giordano A
    Oncogene; 2001 Apr; 20(15):1832-8. PubMed ID: 11313931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of murine cdk10: association with Ets2 transcription factor and effects on the cell cycle.
    Bagella L; Giacinti C; Simone C; Giordano A
    J Cell Biochem; 2006 Oct; 99(3):978-85. PubMed ID: 16741970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
    Foos G; Hauser CA
    Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
    Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
    Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ets transcription factors and targets in osteogenesis.
    Raouf A; Seth A
    Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
    Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
    Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence.
    Ohtani N; Zebedee Z; Huot TJ; Stinson JA; Sugimoto M; Ohashi Y; Sharrocks AD; Peters G; Hara E
    Nature; 2001 Feb; 409(6823):1067-70. PubMed ID: 11234019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conserved mechanisms of Ras regulation of evolutionary related transcription factors, Ets1 and Pointed P2.
    Wasylyk C; Bradford AP; Gutierrez-Hartmann A; Wasylyk B
    Oncogene; 1997 Feb; 14(8):899-913. PubMed ID: 9050989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ets-2 regulates cdc2 kinase activity in mammalian cells: coordinated expression of cdc2 and cyclin A.
    Wen SC; Ku DH; De Luca A; Claudio PP; Giordano A; Calabretta B
    Exp Cell Res; 1995 Mar; 217(1):8-14. PubMed ID: 7867724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
    Watson DK; Robinson L; Hodge DR; Kola I; Papas TS; Seth A
    Oncogene; 1997 Jan; 14(2):213-21. PubMed ID: 9010223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and viral trans-acting factors modulate N-myc2 promoter activity in woodchuck liver tumors.
    Flajolet M; Gegonne A; Ghysdael J; Tiollais P; Buendia MA; Fourel G
    Oncogene; 1997 Aug; 15(9):1103-10. PubMed ID: 9285565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model for gene evolution of the ets-1/ets-2 transcription factors based on structural and functional homologies.
    Albagli O; Soudant N; Ferreira E; Dhordain P; Dewitte F; Begue A; Flourens A; Stehelin D; Leprince D
    Oncogene; 1994 Nov; 9(11):3259-71. PubMed ID: 7936650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the human stress response gene GADD153 expression: role of ETS1 and FLI-1 gene products.
    Seth A; Giunta S; Franceschil C; Kola I; Venanzoni MC
    Cell Death Differ; 1999 Sep; 6(9):902-7. PubMed ID: 10510472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2.
    Coffer P; de Jonge M; Mettouchi A; Binetruy B; Ghysdael J; Kruijer W
    Oncogene; 1994 Mar; 9(3):911-21. PubMed ID: 8108135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex.
    Butticè G; Duterque-Coquillaud M; Basuyaux JP; Carrère S; Kurkinen M; Stéhelin D
    Oncogene; 1996 Dec; 13(11):2297-306. PubMed ID: 8957070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
    Bessa M; Saville MK; Watson RJ
    Oncogene; 2001 Jun; 20(26):3376-86. PubMed ID: 11423988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse models in the study of the Ets family of transcription factors.
    Bartel FO; Higuchi T; Spyropoulos DD
    Oncogene; 2000 Dec; 19(55):6443-54. PubMed ID: 11175360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDK10/cyclin M is a protein kinase that controls ETS2 degradation and is deficient in STAR syndrome.
    Guen VJ; Gamble C; Flajolet M; Unger S; Thollet A; Ferandin Y; Superti-Furga A; Cohen PA; Meijer L; Colas P
    Proc Natl Acad Sci U S A; 2013 Nov; 110(48):19525-30. PubMed ID: 24218572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of Ets2 or distinct portions of Ets2 can reverse Ras-mediated cellular transformation.
    Foos G; García-Ramírez JJ; Galang CK; Hauser CA
    J Biol Chem; 1998 Jul; 273(30):18871-80. PubMed ID: 9668063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice.
    Sumarsono SH; Wilson TJ; Tymms MJ; Venter DJ; Corrick CM; Kola R; Lahoud MH; Papas TS; Seth A; Kola I
    Nature; 1996 Feb; 379(6565):534-7. PubMed ID: 8596630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.